Rockwell Medical Technologies Inc. (RMTI) Stock Research, Analysis & News

Quick Analysis on Rockwell Medical Technologies Inc. (RMTI) Stock as of June 28, 2017

Previous Closing Price $8.20 is above 50 day moving average of $7.38
Previous Closing Price $8.20 is above 200 day moving average of $6.65
The Price/Earnings To Growth ratio (PEG) is less than 1
The Stock pays no dividend
The closing price $8.20 is less than -48.17% away from its one year target price of $4.25
Current Short Ratio 37.93 is great than 1
Earning per Share $-0.39 is negative. Rockwell Medical Technologies Inc. is lossing money.
EBITDA $-19.87M is negative
It is a very small cap stock with market cap of $436.24M
(See more information about Rockwell Medical Technologies Inc. (RMTI) Stock below)

Rockwell Medical Technologies Inc. (RMTI) Stock Profile Summary

Rockwell Medical Technologies, Inc. manufactures and sells hemodialysis concentrate solutions and dialysis kits to hemodialysis providers, targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally. It manufactures, sells, distributes, and delivers hemodialysis concentrates, as well as a line of ancillary hemodialysis products to hemodialysis providers and distributors located in 37 states and territories, as well as various countries, primarily in Latin America, Asia, and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys, known as end stage renal disease, an advanced stage of chronic kidney disease characterized by the irreversible loss of kidney function. It offers Renal Pure liquid acid concentrates, Dri-Sate dry acid concentrate and mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate, as well as a range of ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Rockwell Medical Technologies sells its products through direct salespeople and independent sales representation companies; and to certain international customers through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.

Rockwell Medical Technologies Inc. (RMTI) Stock Key Statistics Research and Analysis as of June 28, 2017

Stock ExchangeNGM
Market Capitalization$436.24M
Trade Volume (Average Trading Volume)143,951 (292,650)
Price/Sales7.87
Price/Book8.44
Earning/Share$-0.39
Current Year EPS Estimate$-0.39
Next Year EPS Estimate$-0.25
Previous Closing Price$8.20
50 Day Price Moving Average$7.38
200 Day Price Moving Average$6.65
1 yr Target Price$4.25
PEG Ratio-1.06
Short Ratio37.93
EBITDA$-19.87M

Rockwell Medical Technologies Inc. (RMTI) Stock Competitor Research and Analysis

Fresenius Medical Care AG & Co. KGAA (FMS)Watson Pharmaceuticals Inc. (WPI)
Unitedhealth Group, Inc. (UNH)WellPoint Inc. (WLP)
Aetna Inc. (AET)

Mutual Funds with Rockwell Medical Technologies Inc. (RMTI) Stock in its top 10 holdings

FundCategoryRMTI Holding Percentage
Perkins DiscoverySmall Growth6.42%

Latest Market News on Rockwell Medical Technologies Inc. (RMTI)


Click here to find the latest news on Rockwell Medical Technologies Inc. (RMTI)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Fresenius Medical Care AG & Co. KGAA (FMS)
Watson Pharmaceuticals Inc. (WPI)
Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)
Aetna Inc. (AET)